Lipid Lowering Agents
Statins have been the main-stay of lipid management to date, but there remains an unmet clinical need for novel lipid-lowering agents that can target low-density lipoprotein cholesterol (LDL-C) and triglycerides. Six Rx is investigating new molecules with effects on LDL-C, triglycerides and fat absorption.